DE69030044D1 - Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung - Google Patents

Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung

Info

Publication number: DE69030044D1
Authority: DE; Germany
Prior art keywords: acetic acid; acid derivatives; inhibiting effect; aldose reductase; reductase inhibiting
Prior art date: 1989-10-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69030044T

Other languages

English (en)

Other versions

DE384879T1 (de

DE69030044T2 (de

Inventor

Sinji Inukai

Mitsuzi Agata

Manami Umezawa

Yoshihiro Horio

Yasuhiro Ootake

Shohei Sawaki

Masayoshi Goto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wakamoto Pharmaceutical Co Ltd

Original Assignee

Wakamoto Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-03

Filing date

1990-10-03

Publication date

1997-04-10

1990-10-03 Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd

1997-04-10 Publication of DE69030044D1 publication Critical patent/DE69030044D1/de

1997-10-09 Application granted granted Critical

1997-10-09 Publication of DE69030044T2 publication Critical patent/DE69030044T2/de

2010-10-04 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DE69030044T 1989-10-03 1990-10-03 Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung Expired - Fee Related DE69030044T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP25708689		1989-10-03

Publications (2)

Publication Number	Publication Date
DE69030044D1 true DE69030044D1 (de)	1997-04-10
DE69030044T2 DE69030044T2 (de)	1997-10-09

Family

ID=17301550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69030044T Expired - Fee Related DE69030044T2 (de)	1989-10-03	1990-10-03	Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung

Country Status (6)

Country	Link
US (2)	US5068239A (de)
EP (1)	EP0421365B1 (de)
JP (1)	JPH03204875A (de)
DE (1)	DE69030044T2 (de)
HU (2)	HU215432B (de)
RU (2)	RU2052458C1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5605795A (en) *	1986-07-24	1997-02-25	Tropix, Inc.	Assays using chemiluminescent, enzymatically cleavable substituted 1,2-dioxetanes and kits therefor
JPH04297474A (ja) *	1991-03-26	1992-10-21	Wakamoto Pharmaceut Co Ltd	テトラゾール酢酸誘導体
GB9110636D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Chemical compounds
US5262433A (en) *	1991-08-06	1993-11-16	Wakamoto Pharmaceutical Co., Ltd.	Tetrazoleacetic acid derivatives and method of aldose reductase inhibition therewith
JP3621427B2 (ja) *	1997-07-22	2005-02-16	塩野義製薬株式会社	糸球体障害治療または予防剤
AU2002213048A1 (en) *	2000-10-05	2002-04-15	Smith Kline Beecham Corporation	Phosphate transport inhibitors
WO2010091310A1 (en)	2009-02-06	2010-08-12	Elan Pharmaceuticals, Inc.	Inhibitors of jun n-terminal kinase
AU2015215863C1 (en) *	2009-02-06	2016-10-20	Imago Pharmaceuticals, Inc.	Inhibitors of jun n-terminal kinase
WO2019194220A1 (ja) *	2018-04-06	2019-10-10	日本曹達株式会社	（ヘテロ）アリールスルホンアミド化合物および有害生物防除剤
MA53086B1 (fr) *	2018-07-05	2024-07-31	Bayer Aktiengesellschaft	Thiophènecarboxamides substitués et analogues comme agents antibactériens
WO2020261144A1 (en) *	2019-06-28	2020-12-30	Pfizer Inc.	5-(thiophen-2-yl)-1h-tetrazole derivatives as bckdk inhibitors useful for treating various diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1261835A (en) *	1984-08-20	1989-09-26	Masaaki Toda	(fused) benz(thio)amides
GB8725260D0 (en) *	1987-10-28	1987-12-02	Lilly Industries Ltd	Organic compounds

1990
- 1990-09-05 JP JP2233220A patent/JPH03204875A/ja active Granted
- 1990-09-24 US US07/588,057 patent/US5068239A/en not_active Ceased
- 1990-10-02 HU HU6305/90A patent/HU215432B/hu not_active IP Right Cessation
- 1990-10-02 RU SU904831469A patent/RU2052458C1/ru active
- 1990-10-03 DE DE69030044T patent/DE69030044T2/de not_active Expired - Fee Related
- 1990-10-03 EP EP90118900A patent/EP0421365B1/de not_active Expired - Lifetime
1992
- 1992-09-25 US US07/951,720 patent/USRE35321E/en not_active Expired - Lifetime
1994
- 1994-08-24 RU RU94031212/04A patent/RU94031212A/ru unknown
1995
- 1995-06-06 HU HU95P/P00166P patent/HU211166A9/hu unknown

Also Published As

Publication number	Publication date
JPH03204875A (ja)	1991-09-06
HU211166A9 (en)	1995-11-28
RU2052458C1 (ru)	1996-01-20
EP0421365A2 (de)	1991-04-10
HU906305D0 (en)	1991-04-29
US5068239A (en)	1991-11-26
EP0421365A3 (en)	1992-01-02
HUT59132A (en)	1992-04-28
HU215432B (hu)	1999-04-28
USRE35321E (en)	1996-08-27
EP0421365B1 (de)	1997-03-05
JPH0583551B2 (de)	1993-11-26
DE69030044T2 (de)	1997-10-09
RU94031212A (ru)	1996-08-10

Publication	Publication Date	Title
FI945688A7 (fi)	1995-06-04	Etikkahappojohdannaisia
FI954404A7 (fi)	1995-09-18	Fenoksifenyylietikkahappojohdannaiset
FI933260A7 (fi)	1994-01-22	Heteroaettiksyraderivat
FI922953A7 (fi)	1992-12-28	7-azaisoindolinylkinolon- och naftyridonkarboxylsyraderivat
FI922873A7 (fi)	1992-12-23	7-isoindolinyl-kinolon- och -naftyridonkarboxylsyraderivat
FI953968A7 (fi)	1995-10-19	Antraniiliset happojohdannaiset
FI921163A7 (fi)	1992-09-27	N-acyl-a-aminosyraderivat
FI943948L (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
FI933471L (fi)	1993-08-05	Polyhydroxikarboxylsyra och foerfarande foer dess framstaellning
FI942049L (fi)	1994-11-07	Bentsofuranyyli- ja tiofenyylialkaanikarboksyylihappojohdannaisia
FI940659A7 (fi)	1994-08-16	Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
FI922095L (fi)	1992-11-10	Substituerade karboxylsyraderivat
NO923580L (no)	1993-04-02	Substituerte imidazolylpropensyrederivater
FI942976A7 (fi)	1995-02-28	5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
DE69030044D1 (de)	1997-04-10	Tetrazolessigsäurederivate mit Aldosereduktase inhibierender Wirkung
FI941712A7 (fi)	1994-10-16	Heterosykliset iminobismetyleenibisfosfonihappojohdannaiset
FI924354L (fi)	1993-04-02	Imidazolylpropensyraderivat
FI925469A7 (fi)	1993-06-04	Tiatsolyylillä substituoidut kinolyylimetoksifenyylietikkahappojohdannaiset
FI925545A7 (fi)	1992-12-07	Bentsoehappojohdannaisia
DE59402621D1 (de)	1997-06-12	Fluor-trifluormethylbenzoesäure-Derivate
FI932953A7 (fi)	1993-12-27	Imidazolylsubstituerade fenylpropion- och -kanelsyraderivat
FI906104A7 (fi)	1991-06-14	Naftyylisulfonyylialkaanihappojohdannaisia
FI933512A7 (fi)	1994-02-12	2-substituerade kinolinylmetoxifenylaettiksyraderivat
FI930462A7 (fi)	1993-08-05	Aminobensoesyraderivat
FI941064A7 (fi)	1994-09-12	Asyylioksiheksaanihappojohdannaiset

Legal Events

Date	Code	Title	Description
1998-04-02	8364	No opposition during term of opposition
2004-08-26	8339	Ceased/non-payment of the annual fee